# FDA Inspection 1122657 - Biotest Pharmaceuticals Corporation - February 21, 2020

Source: https://www.keypedia.com/records/fda_inspections/biotest-pharmaceuticals-corporation/93a61f95-9d23-422b-b546-f52f073309be
Source feed: FDA_Inspections

> FDA Inspection 1122657 for Biotest Pharmaceuticals Corporation on February 21, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122657
- Company Name: Biotest Pharmaceuticals Corporation
- Inspection Date: 2020-02-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 999138 - 2016-10-13](https://www.keypedia.com/records/fda_inspections/biotest-pharmaceuticals-corporation/9d3a00c3-a8d4-4914-af58-9e1842182e04)

Company: https://www.keypedia.com/companies/biotest-pharmaceuticals-corporation/fd2e9f1c-e395-443b-be7c-d1928cd5e4af

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d